Skip to content

Effect of Ondansetron on thermal pain levels (heat and cold), mechanical and pain control mechanisms in humans

Effect of Ondansetron on the threshold of thermal and mechanical pain and conditioned modulation of pain in humans

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4xktdc
Enrollment
Unknown
Registered
2020-03-27
Start date
2018-03-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Serotonin 5ht3 receptors

Interventions

-pain thresholds to hot and cold
this study’s objective was to evaluate ondansetron’s effect on mechanical and thermal pain thresholds, as well as CPM in humans. 17 volunteers, who were randomly selected and double blinded, partici
2 - NaCl at 0.9% and 8 mg ondansetron in a volume of 20 mL. Before each intervention, the following basic tests were performed: Using the quantitative sensitivity test (QST) Algometer and TSA,2001
Medoc Ltd, we obtained: -the thresholds for detecting warm and cold
-the pressure pain threshold. -CPM was evaluated using the parallel paradigm in which two identical nociceptive test stimuli were induced before and simultaneous to a conditioned nociceptive stimulu
Drug
Device
D27.505.519.625.850.850.300
F02.830.816.781
C10.597.751.791.400

Sponsors

Universidade do Estado do Rio de Janeiro
Lead Sponsor
Universidade do Estado do Rio de Janeiro
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Healthy individuals of both sexes, aged between 18 and 60 years, with classification of physical status by the American Society of Anesthesiologists - ASA I, were invited to participate in the project.

Exclusion criteria

Exclusion criteria: Individuals with chronic pain, defined as pain lasting more than 3 months, of any origin were not included. as well as those who used analgesics, antidepressants, benzodiazepines or any drug with psychoactive action in the last 14 days prior to the tests

Design outcomes

Primary

MeasureTime frame
Expected outcome 1 - Evaluation of thermal and mechanical pain thresholds and conditioned pain modulation. Increase in heat detection threshold. Evaluated by semiquantitative sensory test (Medoc TSA-2001; Medoc Ltd., Ramat Yishai, Israel). Verified by Wilcoxon statistical test, with p 0.05%);Expected outcome 3: Evaluation of mechanical pain thresholds - There was no statistical significance (p> 0.05%).;Expected outcome: Evaluation of pain-conditioned modulation - Ondansetron improved CPM, with statistical significance (p >0.05%).

Secondary

MeasureTime frame
Outcome found 1: The results, in our series, revealed an increase in the threshold of thermal detection and heat pain, with the use of ondansetron (P 0.05%).;Outcome found 4: Evaluation of conditioned pain modulation. There was an improvement in CPM, after the administration of ondansetron, with statistical significance ( p > 0.05%). This suggests a central role occasioned by serotonergic antagonism (5HT3)

Countries

Brazil

Contacts

Public ContactBruno Santiago

Universidade do Estado do Rio de Janeiro

druerj2013@gmail.com55-021-998124018

Outcome results

None listed

Source: REBEC (via WHO ICTRP)